Molecular belt models for the apolipoprotein A-I Paris and milano mutations

Biophysical Journal

Volumn 79, Issue 3, 2000, Pages 1679-1685

  Klon, Anthony E ^a   Jones, Martin K ^b   Segrest, Jere P ^a,b   Harvey, Stephen C ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; MUTANT PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; DISULFIDE BOND; MOLECULAR MODEL; MUTATION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

EID: 0033849918     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(00)76417-4     Document Type: Article

References (18)

1. 3) from porcine plasma. Proc. R. Soc. Lond. B. 186:165-180.
2. Borhani, D. W., D. P. Rogers, J. A. Engler, and C. G. Brouillette. 1997. Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. Proc. Natl. Acad. Sci. USA. 94:12291-12296.
3. Brasseur, R., J. De Meutter, B. Vanloo, E. Goormaghtigh, J. M. Ruysschaert, and M. Rosseneu. 1990. Mode of assembly of amphipathic helical segments in model high-density lipoproteins. Biochim. Biophys. Acta. 1043:245-252.
4. Carson, M. 1997. Ribbons. Methods Enzymol. 277:493-505.
5. Castelli, W. P., R. J. Garrison, P. W. F. Wilson, R. D. Abbott, S. Kalousdian, and W. B. Kannel. 1986. Incidence of coronary heart disease and lipoprotein cholesterol levels. JAMA. 256:2835-2838.
6. Paris is defective in activation of lecithin: cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux. J. Mol. Med. 77:614-622.
7. Fielding, C. J., and P. E. Fielding. 1995. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36:211-228.
8. Milano carriers and transgenic mice. Arterioscler. Thromb. Vasc. Biol. 19:1257-1262.
9. Milano Apoprotein-decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J. Clin. Invest. 66:892-900.
10. Jonas, A., J. H. Wald, K. L. H. Toohill, E. S. Krul, and K. E. Kézdy. 1990. Apolipoprotein A-I structure and lipid properties in homogeneous, reconstituted spherical and discoidal high density lipoproteins. J. Biol. Chem. 265:22123-22129.
11. Jones, M. K., G. M. Anantharamaiah, and J. P. Segrest. 1992. Computer programs to identify and classify amphipathic a helical domains. J. Lipid Res. 33:287-296.
12. Koppaka, V., L. Silvestro, J. Engler, C. Brouillette, and P. H. Axelsen. 1999. The structure of human lipoprotein A-I. J. Biol. Chem. 274:14541-14544.
13. Miller, G. J., and N. E. Miller. 1975. Plasma-high-density-lipoprotein concentration and development of ischaemic heart disease. Lancet. i:16-19.
14. Miller, N. E., D. S. Thelle, O. H. Førde, and O. D. Mjøs. 1977. The Tromsø Heart Study: high-density lipoprotein and coronary heart disease: a prospective case-control study. Lancet. i:965-968.
15. 2 and class Y amphipathic helical peptides with membranes. Biochemistry. 35:11210-11220.
16. Nolte, R. T., and D. Atkinson. 1992. Conformational analysis of apolipoprotein A-I and E-3 based on primary sequence and circular dichroism. Biophys. J. 63:1221-1239.
17. Palgunachari, M. N., V. K. Mishra, S. Lund-Katz, M. C. Phillips, S. O. Adeyeye, S. Alluri, G. M. Anantharamaiah, and J. P. Segrest. 1996. Only the two end helixes of eight tandem amphipathic helical domains of human Apo A-I have significant lipid affinity: implications for HDL assembly. Arterioscler. Thromb. Vasc. Biol. 16:328-338.
18. Phillips, J. C., W. Wriggers, Z. Li, A. Jonas, and K. Schulten. 1997. Predicting the structure of apolipoprotein A-1 in reconstituted high-density lipoprotein disks. Biophys. J. 73:2337-2346.